PUNE, India, Sept. 13, 2012 /PRNewswire-iReach/ -- PPCE, a high-quality Clinical Data Management services company providing CDISC-certified services announced today that it has entered into a strategic partnership agreement with ECLINSO AG, a leading provider of eClinical information technology, consulting and business process outsourcing services.
PPCE Data Management Services and ECLINSO's Trialforce Platform offer unparalleled flexibility and adaptability to both Sponsors and Clinical Research Organizations (CROs) for capturing and managing their clinical data.
With extensive experience in serving pharmaceutical and biotechnology companies of all sizes, PPCE, a company based in Pune, India has selected ECLINSO's Trialforce platform to enable it to offer high-quality eClinical application services and optimized data management services to their clients.
Trialforce a single, unified application platform is a comprehensive, on demand, SaaS based solution for conducting Clinical Trials. It offers enterprise class software for Electronic Data Capture (EDC), Electronic Source Record (ESR), eTMF aligned Document Management (DMS), Diagnostic imaging, and Regulatory Solutions (eCTD).
ECLINSO's strong foundation of managed IT services, dedicated on demand servers and global 24/7 support, offers Sponsors and Clinical Research Organizations CDISC compliant solutions designed to accelerate clinical development.
"PPCE is delighted to have reached this partnership agreement with ECLINSO, enabling us to offer enterprise class eClinical solutions and services.
ECLINSO's Trialforce platform accelerates the whole clinical trial process and thus saves time and money which will enable PPCE to efficiently continue providing its clients with the high-quality eClinical solutions and services they have come to expect. Our combined experience and resources will significantly improve clinical trial efficiency while reducing costs for our clients," stated Firdaus Dastoor, Chairman PPCE.
"PPCE's strong presence with global organizations and proven established execution capability throughout Asia will enable ECLINSO to fulfill increasing customer demand for its Trialforce platform," said Frank Pijpers, CEO ECLINSO.
About ECLINSO (www.eclinso.com)
ECLINSO is an innovative provider of Clinical Technology solutions and global support services to enhance the conduct of clinical trials. Our international reputation combined with our deep industry understanding and innovative approach through Trialforce is setting the benchmark for the use of 'on demand' solutions for clinical trials. Through Trialforce we deliver an innovative standards, affordable, scalable and easy-to-use platform that enables sponsors and CRO's to rapidly deploy an integrated EDC/Data Management/eClinical suite. The solution is based on an uncomplicated SaaS pricing model, that offers minimal upfront costs and significantly lower initial licensing fees compared to those fees traditionally associated with the use of EDC solutions.
ECLINSO was formed in 1995 and has offices in Basel, Switzerland, New Jersey and California, USA.
About PPCE (www.ppceworld.com)
Established in 1997, PPCE offers cost effective clinical data management and bio-statistical services for paper based, electronic and hybrid studies. Solutions used are validated, world renowned and regulatory compliant across the globe. Fully validated, 21 CFR Part 11 compliant platforms like Oracle Clinical and Trialforce enable PPCE to offer its clients world class tools for high quality data.
We are a company focused on quality and on-time delivery for our clients. PPCE's sixteen years of experience certifying companies for quality management means that critical aspects of quality, such as integrity of data, confidentiality and customer orientation, form part of the organizational culture. As a result of this culture we enjoy a high level of customer satisfaction and long term relationships with our clients.
+ 91 20 2674 5024
Media Contact: George Masoura ECLINSO, 855 245 0987, email@example.com
News distributed by PR Newswire iReach: https://ireach.prnewswire.com
Copyright©2012 PR Newswire.
All rights reserved